Leis H J, Leis M, Windischhofer W
University Childrens Hospital, Department of Biochemical Analysis and Mass Spectrometry, University of Graz, Austria.
J Mass Spectrom. 1996 May;31(5):486-92. doi: 10.1002/(SICI)1096-9888(199605)31:5<486::AID-JMS321>3.0.CO;2-L.
A method for the quantitative measurement of the non-steroidal anti-inflammatory drug ketoprofen in human plasma and urine is presented. The assay is based on gas chromatography/negative ion chemical ionization mass spectrometry. The preparation of stable isotope-labelled ketoprofen for use as an internal standard is described. After solvent extraction from the acidified matrix, urine samples were analysed as pentafluorobenzyl esters, whereas plasma samples required further derivatization to the hydroxylamine-trimethylsilyl derivatives. The detection limit was found to be 5 pg in both cases. The method was applied to the pharmacokinetics of ketoprofen in man after epidermal application.
本文介绍了一种定量测定人血浆和尿液中非甾体抗炎药酮洛芬的方法。该测定基于气相色谱/负离子化学电离质谱法。描述了用作内标物的稳定同位素标记酮洛芬的制备方法。从酸化基质中进行溶剂萃取后,尿液样品以五氟苄酯形式进行分析,而血浆样品则需要进一步衍生化为羟胺-三甲基硅烷基衍生物。两种情况下的检测限均为5皮克。该方法应用于表皮给药后酮洛芬在人体的药代动力学研究。